No black box warning on record for Zynrelef

As of the latest FDA labeling reviewed, Zynrelef (BUPIVACAINE AND MELOXICAM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Zynrelef medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Dose-Related Toxicity : Monitor cardiovascular and respiratory vital signs and patient's state of consciousness after application of ZYNRELEF ( 5.3 ). When using ZYNRELEF with other local anesthetics, overall local anesthetic exposure must be considered through 72 hours ( 5.3 ). Hepatotoxicity : If abnormal liver tests persist or worsen, perform a clinical evaluation of

No black box warning on record for Zynrelef

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Dose-Related Toxicity : Monitor cardiovascular and respiratory vital signs and patient's state of consciousness after application of ZYNRELEF ( 5.3 ). When using ZYNRELEF with other local anesthetics, overall local anesthetic exposure must be considered through 72 hours ( 5.3 ). Hepatotoxicity : If abnormal liver tests persist or worsen, perform a clinical evaluation of

Zynrelef Black Box Warning

No black box warning on record for Zynrelef

Other warnings & precautions

Zynrelef Black Box Warning

No black box warning on record for Zynrelef

Other warnings & precautions